THE CLINICAL USE OF SULPHANILAMIDE AND ITS DERIVATIVES IN THE TREATMENT OF INFECTIOUS DISEASES
Authors: Perrin H. Long, Eleanor A. Bliss
Journal: Annals of Internal Medicine (1937)

Article1 October 1937THE CLINICAL USE OF SULPHANILAMIDE AND ITS DERIVATIVES IN THE TREATMENT OF INFECTIOUS DISEASESPERRIN H. LONG, M.D., ELEANOR A. BLISS, Sc.D.PERRIN H. LONG, M.D.Search for more papers by this author, ELEANOR A. BLISS, Sc.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-11-4-575 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONThe experimental observations 1, 2, 3, 4, 5, 6, 7 which have led to the use of sulphanilamide or its derivatives (chart 1) in the treatment of certain infectious diseases show that these chemicals have powerful chemotherapeutic effects in experimental infections. Clinical observations of their effects in human beings tend to confirm the laboratory results. In this communication we propose to discuss primarily the clinical application of these chemotherapeutic agents, and to detail the methods of their administration and the possible toxic effects which may become manifest in patients treated with sulphanilamide or its derivatives.It is interesting to...Bibliography1. DOMAGK G: Ein Beitrag zur Chemotherapie der bakteriellen Infektionen, Deutsch. med. Wchnschr., 1935, lxi, 250. CrossrefGoogle Scholar2. TREFOUELTREFOUELNITTIBOVET JJFD: Activite du p-aminophenylsulfamide sur les infections streptococciques experimentales de la souris et du lapin, Compt. rend. Soc. de biol., 1935, cxx, 756. Google Scholar3. COLEBROOKKENNY LM: Treatment of human puerperal infections in mice with prontosil, Lancet, 1936, i, 1279-1286. CrossrefGoogle Scholar4. BUTTLEGRAYSTEPHENSON GAWHD: Protection of mice against streptococcal and other infections by p-aminobenzenesulphonamide and related substances, Lancet, 1936, i, 1286. CrossrefGoogle Scholar5. LONGBLISS PHEA: Para-amino-benzene-sulfonamide and its derivatives, Jr. Am. Med. Assoc., 1937, cviii, 32-37. CrossrefGoogle Scholar6. ROSENTHAL SM: Studies in chemotherapy; chemotherapy of experimental pneumococcus infections, U. S. Pub. Health Rep., 1937, lii, 48-53. CrossrefGoogle Scholar7. PROOM H: Therapeutic action of p-aminobenzenesulphonamide in meningococcal infections in mice, Lancet, 1937, i, 16-18. CrossrefGoogle Scholar8. FOERSTER : Sepsis im Anschluss an ausgedehnte Periporitis Heilung durch Streptozon, Zentralbl. f. Haut.-Geschlenkskr., 1933, xlv, 549. Google Scholar9. GRUTZ O: Erythema exsudativum multiforme bullosum faciei, colli et extremitatum, Zentralbl. f. Haut.-Geschlenkskr., 1934, xlix, 300. Google Scholar10. GRUTZ O: Beitrag zur Kenntnis der infektiös-toxischen, Erythema-exsudativum-multiforme-ähnlichen Exantheme, Med. Klin., 1934, xxx, 52. Google Scholar11. VEIL WH: Therapie des Rheumatismus, Nachtrag, Therap. d. Gegenw., 1934, lxxv, 212-215. Google Scholar12. GMELIN L: Zur Chemotherapie des Erysipels im Kindesalter, München. med. Wchnschr., 1935, lxxxii, 221-222. Google Scholar13. KLEEROMER PH: Prontosil bei Streptokokkenerkrankungen, Deutsch. med. Wchnschr., 1935, lxi, 253-255. CrossrefGoogle Scholar14. SCHREUS HT: Chemotherapie des Erysipels und anderer Infektionen mit Prontosil, Deutsch. med. Wchnschr., 1935, lxi, 255-256. CrossrefGoogle Scholar15. ANSELM E: Unsere Erfahrungen mit Prontosil bei Puerperalfieber, Deutsch. med. Wchnschr., 1935, lxi, 264. Google Scholar16. GANTENBERG R: Munster i W., Medizinisch-naturwissenschaftliche Gesellschaft (Medizinische Abteilung), 5. und 19, XI, 1934, Deutsch. med. Wchnschr., 1935, lxi, 284. Google Scholar17. IMHÄUSER K: Über die Behandlung septischer Erkrankungen mit Prontosil, Med. Klin., 1935, xxxi, 282-285. Google Scholar18. RECKNAGEL K: Erfahrungen mit Prontosil, Münch. med. Wchnschr., 1935, lxxxii, 704. Google Scholar19. BINGOLD K: Erfolgreiche Behandlung von Hodgkin-Wechsel-Fieber mit Prontosil, München. med. Wchnschr., 1935, lxxxii, 871. Google Scholar20. EINHAUSER : Aerztlicher Verein München e. V. und Militärärztliche Gesellschaft München, May 22, 1935; München. med. Wchnschr., 1935, lxxxii, 1263. Sepsisbehandlung mit Prontosil, Deutsch. med. Wchnschr., 1935, lxi, 1463. Google Scholar21. FUGE K: Die Behandlung der puerperalsepsis mit Prontosil, Deutsch. med. Wchnschr., 1935, lxi, 1672. CrossrefGoogle Scholar22. ROTH A: Heilung eines Falles von Streptokokkensepsis unter Prontosil-behandlung, Deutsch. med. Wchnschr., 1935, lxi, 1734. Google Scholar23. SCHRANZ H: Zur Sepsisbehandlung mit Prontosil, München. med. Wchnschr., 1935, lxxxii, 419-420. Google Scholar24. RIECKE H: Zur Therapie der Meningitis, Ztschr. f. Hals-, Nasen-u. Ohrenh., 1935, xxxviii, 175-177. Google Scholar25. SCHERBER G: Die Behandlung des Rotlauf mit interner Prontosiltherapie kombiniert mit intravenösen Omnadininjektionen, Wien. med. Wchnschr., 1935, lxxxv, 284, 346 and 783-784. Zur Behandlung der verschiedenen Formen des Pemphigus chronicus mit Antileprol und Prontosil, Wien. med. Wchnschr., 1936, lxxxvi, 22-24. Google Scholar26. KRAMER W: Ueber Erfahrungen bei der Erysipelbehandlung mit Prontosil, München. med. Wchnschr., 1936, lxxxiii, 608-610. Google Scholar27. VERMELINHARTEMANN H: De l'emploi du chlorhydrate de sulfamido-chrisoidine en injections intraveineuses dans le traitement de l'I.P., Bull. Soc. d'obst. et de gynec., 1936, xxv, 158-161. Google Scholar28. FLOCH H: Le traitement de la lymphangite endémique des pays chauds par le chlorhydrate de sulfamido-chrysiodine, Bull. Soc. path. exot., 1936, xxix, 165-168. Google Scholar29. LEMIÈRRELA PORTELAUDATDAUM : Nephrite erysipelateuse. Action du bicarbonate de soude ingéré sur l'acidose. Innocuité du chlorhydrate de sulfamido-chysiodine pour le rein malade, Bull. et mém. Soc. méd. d. hôp. de Paris, 1936, lii, 535-540. Google Scholar30. MEYER-HEINEHUGUENIN AP: Traitement de l'érysipèle par le chlorhydrate de sulfamido-chrysoidine, Presse méd., 1936, xliv, 454-457. Google Scholar31. BLOCH-MICHELCONTEDUREL HMP: L'emploi des dérivés sulfamidés non azóiques dans le traitement de l'érysipèle, Presse méd., 1936, xliv, 1583. Google Scholar32. COLEBROOKKENNY LM: Treatment with prontosil of puerperal infections due to haemolytic streptococci, Lancet, 1936, ii, 1319-1322. CrossrefGoogle Scholar33. FOULISBARR MAJB: Prontosil album in puerperal sepsis, British Med. Jr., 1937, i, 445-446. CrossrefGoogle Scholar34. PETERSHAVARD BARV: Chemotherapy of streptococcal infections with p-Benzylamino-benzenesulphonamide, Lancet, 1937, i, 1273. CrossrefGoogle Scholar35. SCHWENTKERGELMANLONG FFSPH: The treatment of meningococcic meningitis with sulfanilamide, Jr. Am. Med. Assoc., 1937, cviii, 1407-1408. CrossrefGoogle Scholar36. DEESCOLSTON JEJA: The use of sulfanilamide in gonococcic infections, Jr. Am. Med. Assoc., 1937, cviii, 1855-1858. CrossrefGoogle Scholar37. HEINTZELMANHADLEYMELLON JHPBRR: The use of p-amino-benzenesulphonamide in Type III pneumococcus pneumonia, Am. Jr. Med. Sci., 1937, cxciii, 759. CrossrefGoogle Scholar38. LONGBLISS PHEA: Para-aminobenzenesulfonamide and its dervatives, Arch. Surg., 1937, xxxiv, 351-359. CrossrefGoogle Scholar39. BLISSLONG EAPH: The failure of para-aminobenzenesulfonamide therapy in urinary tract infections due to Group D (Lancefield) Beta hemolytic streptococci, New Eng. Jr. Med., 1937, ccxvii, 18-21. CrossrefGoogle Scholar40. LONGBLISS PHEA: The use of para amino benzene sulphonamide (sulphanilamide) or its derivatives in the treatment of infections due to Beta hemolytic streptococci, pneumococci and meningococci, South. Med. Jr., 1937, xxx, 479-487. CrossrefGoogle Scholar41. LONGBLISS PHEA: To be published. Google Scholar42. ROSENTHAL SM: Studies in chemotherapy; effect of p-aminobenzenesulphonamide on pneumococci in vitro, U. S. Pub. Health Rep., 1937, lii, 192. CrossrefGoogle Scholar43. COOPERGROSSMELLON FBPRR: Action of p-aminobenzenesulfonamide on Type III pneumococcus infections in mice, Proc. Soc. Exper. Biol. and Med., 1937, xxxvi, 148; and Efficacy of p-aminobenzenesulfonamide in experimental Type III pneumococcus pneumonia, ibid., 225. CrossrefGoogle Scholar44. GRAY HJ: Streptococcic meningitis; report of case with recovery, Jr. Am. Med. Assoc., 1935, cv, 92-95. CrossrefGoogle Scholar45. CAUSSÉLOISEAUGISSELBRECHT : Meningite purulente otogene a streptocoques, traitee exclusivement par un colorant azoique Guerison, Ann. d. otolaryng., 1936, 194-199. Google Scholar46. ARNOLD JG: Treatment of hemolytic meningitis with para-amino-benzene-sulfonamide; report of case with recovery, ANN. INT. MED., 1937, x, 1198. Google Scholar47. ARNOLD JG: Personal communication. Google Scholar48. SCHWENTKERCLASONMORGANLINDSAYLONG FFFPWAJWPH: The use of para-amino-benzene-sulphonamide or its derivatives in the treatment of Beta haemolytic streptococcal meningitis, Bull. Johns Hopkins Hosp., 1937, lx, 297-306. Google Scholar49. ANDERSON ED: Hemolytic streptococcus meningitis, Jr. Am. Med. Assoc., 1937, cviii, 1591-1592. CrossrefGoogle Scholar50. WEINBERGMELLONSHINN MHRRLE: Two cases of streptococcic meningitis, Jr. Am. Med. Assoc., 1937, cviii, 1948. CrossrefGoogle Scholar51. FROST LD: Sulphaemoglobinemia following anti-streptococcal chemotherapy, Lancet, 1937, i, 510. CrossrefGoogle Scholar52. PLUMER A: Prontylin and prontosil (correspondence), New Eng. Jr. Med., 1937, ccxvi, 711. Google Scholar53. TRUMPER A: Prontylin and prontosil (correspondence), New Eng. Jr. Med., 1937, ccxvi, 857. Google Scholar54. SOUTHWORTH H: Acidosis associated with the administration of para-amino-benzene-sulfonamide (Prontylin), Proc. Soc. Exper. Biol. and Med., 1937, xxxvi, 58-61. CrossrefGoogle Scholar55. SCHWENTKER FF: Personal communication (in press Bull. Johns Hopkins Hosp.) 1937. Google Scholar56. MARSHALLEMERSONCUTTING EKKWC: Para-aminobenzenesulfonamide, Jr. Am. Med. Assoc., 1937, cviii, 953-957. CrossrefGoogle Scholar57. MARSHALL EK: Determination of sulfanilamide in blood and urine, Proc. Soc. Exper. Biol. and Med., 1937, xxxvi, 422-424. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Baltimore, Maryland*Read at the St. Louis meeting of the American College of Physicians, April 20, 1937.From the Department of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland.Our investigations have been made possible by a grant from the Chemical Foundation, Inc., of New York City. Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byEvaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective EndocarditisRevisiting "the origins of compulsory drug prescriptions".Bacillus welchii infection of the prostate and its treatmentAgranulocytosis caused by Amidopyrine and by Drugs of the Sulfanilamide GroupSulfanilamide in Meningococcic InfectionsThe Treatment of Gonococcal Infections with Sulfanilamide, Sulfapyridine and Allied CompoundsNewer Research Findings for Dealing with Syphilis and GonorrheaOn sulphanilamid agranulocytosisSulfanilamide and Disulfanilamide Concentrations in the Blood and UrineSulfanilyl-Sulfanilamide in the Treatment of Gonorrhea in the MaleGRANULOCYTOPENIA FOLLOWING THE ADMINISTRATION OF SULPHANILAMIDE COMPOUNDSSulfanilamide: a Review of the Clinical and Experimental Work on its Therapeutic Properties**From the Walter G. Zoller Memorial Dental Clinic, University of Chicago.Granulocytopenia and hyperleucocytosis following sulfanilamide therapyTHE DETERMINATION OF SULFANILAMIDE IN TUNGSTIC ACID BLOOD FILTRATES BY MEANS OF SODIUM β-NAPHTHOQUINONE-4-SULFONATE 1 October 1937Volume 11, Issue 4Page: 575-592KeywordsChartsChemotherapeutic agentsHospital medicineInfectious diseasesResearch laboratories ePublished: 1 December 2008 Issue Published: 1 October 1937 Copyright & PermissionsCopyright, 1937, by The American College of PhysiciansPDF downloadLoading ...